Karilyn Theresamela Larkin MD (She/Her)
Hematologic Oncology
Assistant Professor of Internal Medicine, Division of Hematology
Join to View Full Profile
460 W 10th AveColumbus, OH 43210
Phone+1 614-293-3989
Fax+1 614-293-7484
Dr. Larkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Karilyn Larkin is a hematologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. She received her medical degree from Albany Medical College and has been in practice 7 years. She specializes in hematologic oncology.
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2013 - 2016- Ohio State University HospitalResidency, Internal Medicine, 2010 - 2013
Albany Medical CollegeClass of 2010
Certifications & Licensure
OH State Medical License 2010 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Leukemia-driven expansion of type 3 innate lymphoid cell facilitates a pro-tumoral microenvironment in acute myeloid leukemia.Thanh Thanh T Dinh, Matthew R Lordo, Amy Y Zhang, Chinmayee Goda, Nikolas Shilo
Leukemia. 2026-02-01 - Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML.Jayanshu Jain, Kelly Pugh, Shivani Handa, Kaitlyn M Dvorak-Kornaus, Qiuhong Zhao
Blood Neoplasia. 2026-02-01 - Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid...Monica Cusan, Karilyn Larkin, Deedra Nicolet, Vindi Jurinovic, Krzysztof Mrózek
Leukemia. 2025-12-01
Journal Articles
- MicroRNA-29b mediates altered innate immune development in acute leukemia.Mundy-Bosse BL, Scoville SD, Chen L, McConnell K, Mao HC, Ahmed EH, Zorko N, Harvey S, Cole J, Zhang X, Costinean S, Croce CM, Larkin K, Byrd JC, Vasu S, Blum W, Yu J,..., JCI, 10/24/2016
- Targeting BTK through microRNA in chronic lymphocytic leukemia.Bottoni A, Rizzotto L, Lai TH, Liu C, Smith LL, Mantel R, Reiff S, El-Gamal D, Larkin K, Johnson AJ, Lapalombella R, Lehman A, Plunkett W, Byrd JC, Blachly JS, Woyach ..., Blood, 10/17/2016
Abstracts/Posters
- NPM1 mutations Using Deep Amplicon Sequencing and Broad Next Generation Sequencing at the Time of Complete Remission Is Informative to Predicting Risk of Relapse Follo...Karilyn Larkin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell TransplantationKarilyn Larkin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
An Aggressive Leukemia Is More Lethal for Black PatientsJuly 7th, 2022- Young Black People with This Type of Leukemia Have Worse OutcomesJuly 7th, 2022
- Young Black Patients with AML Have Significantly Worse Outcomes Than White Patients of Same AgeJuly 5th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
